Alsactide

Star0

DB13298ExperimentalSmall molecule

Alsactide: Overview.

Mechanism: Pharmacologically active on Adrenocorticotropic hormone receptor
Curator reviewed
Formula / weight: C₉₉H₁₅₅N₂₉O₂₁S · 2119.57 g/mol (avg)
Code names: HOE-433

Resolves to

Compound

UNIIJ0K70H3420CAS34765-96-3ChEMBLCHEMBL3989434ChEBI135911

Clinical / RWD

ATCV04CH04

Structure

InChIKeyDIDCGVRALANKIU-OTEFFYEFSA-NSMILES

CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)CCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCCCCN

Targets

Q01718MC2R

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1ATC codeIncluding every combination product, plus 15 drug categories

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Alsactide, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account